AU2005250464B2 - Unagglomerated core/shell nanocomposite particles - Google Patents

Unagglomerated core/shell nanocomposite particles Download PDF

Info

Publication number
AU2005250464B2
AU2005250464B2 AU2005250464A AU2005250464A AU2005250464B2 AU 2005250464 B2 AU2005250464 B2 AU 2005250464B2 AU 2005250464 A AU2005250464 A AU 2005250464A AU 2005250464 A AU2005250464 A AU 2005250464A AU 2005250464 B2 AU2005250464 B2 AU 2005250464B2
Authority
AU
Australia
Prior art keywords
nanocomposite particles
suspension
sio
nanocomposite
fluorescein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2005250464A
Other languages
English (en)
Other versions
AU2005250464A1 (en
Inventor
James H. Adair
Mark Kester
Jerry Luck
Carlo G. Pantano
Sarah M. Rouse
Christopher Siedlecki
Lawrence Sinoway
Alan Snyder
Erwin Vogler
Jun Wang
William B. White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Penn State Research Foundation
Original Assignee
Penn State Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Penn State Research Foundation filed Critical Penn State Research Foundation
Publication of AU2005250464A1 publication Critical patent/AU2005250464A1/en
Application granted granted Critical
Publication of AU2005250464B2 publication Critical patent/AU2005250464B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
    • A61K49/0093—Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00—Manufacture or treatment of nanostructures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2989—Microcapsule with solid core [includes liposome]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2993—Silicic or refractory material containing [e.g., tungsten oxide, glass, cement, etc.]
    • Y10T428/2995—Silane, siloxane or silicone coating

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Ceramic Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Composite Materials (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Colloid Chemistry (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Pigments, Carbon Blacks, Or Wood Stains (AREA)
AU2005250464A 2004-06-01 2005-06-01 Unagglomerated core/shell nanocomposite particles Ceased AU2005250464B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US57588704P 2004-06-01 2004-06-01
US60/575,887 2004-06-01
US57921404P 2004-06-14 2004-06-14
US60/579,214 2004-06-14
PCT/US2005/019239 WO2005118702A2 (en) 2004-06-01 2005-06-01 Unagglomerated core/shell nanocomposite particles

Publications (2)

Publication Number Publication Date
AU2005250464A1 AU2005250464A1 (en) 2005-12-15
AU2005250464B2 true AU2005250464B2 (en) 2010-10-07

Family

ID=35463436

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005250464A Ceased AU2005250464B2 (en) 2004-06-01 2005-06-01 Unagglomerated core/shell nanocomposite particles

Country Status (7)

Country Link
US (1) US8071132B2 (enExample)
EP (1) EP1773936B1 (enExample)
JP (1) JP2008501509A (enExample)
KR (1) KR20070028478A (enExample)
AU (1) AU2005250464B2 (enExample)
CA (1) CA2569067C (enExample)
WO (1) WO2005118702A2 (enExample)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ573300A0 (en) * 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
KR20070028478A (ko) 2004-06-01 2007-03-12 더 펜 스테이트 리서치 파운데이션 비응집성 코어/쉘 나노복합 입자
EP1991203A2 (en) * 2006-02-13 2008-11-19 Advanced Materials Technology, Inc. Porous microparticles solid cores
KR100745745B1 (ko) * 2006-02-21 2007-08-02 삼성전기주식회사 나노복합재료 및 그 제조방법
JP2007269770A (ja) * 2006-03-09 2007-10-18 Mitsubishi Chemicals Corp 機能性磁気超ナノ微粒子及びその用途
US7670679B2 (en) 2006-05-30 2010-03-02 General Electric Company Core-shell ceramic particulate and method of making
US20100258759A1 (en) * 2006-06-06 2010-10-14 Cornell Research Foundation, Inc. Nanostructured Metal Oxides Comprising Internal Voids and Methods of Use Thereof
WO2008032327A2 (en) * 2006-09-14 2008-03-20 Yissum Research Development Company Of The Hebrew University Of Jerusalem Organic nanoparticles obtained from microemulsions by solvent evaporation
AR063704A1 (es) 2006-09-14 2009-02-11 Makhteshim Chem Works Ltd Nanoparticulas de pesticida obtenida obtenidas a partir de microemulsiones y nanoemulsiones
JP5486147B2 (ja) * 2006-11-08 2014-05-07 富士フイルム株式会社 顔料分散組成物、それを含有する着色感光性樹脂組成物及び感光性樹脂転写材料、並びにそれらを用いたカラーフィルタ及び液晶表示装置
JP4493044B2 (ja) * 2006-11-27 2010-06-30 株式会社豊田中央研究所 ナノ複合粒子および分子のラッピング方法
KR100791731B1 (ko) 2007-01-04 2008-01-03 고려대학교 산학협력단 자성체 코어 - 세라믹 쉘 나노 결정 및 그의 제조방법
JPWO2008114532A1 (ja) * 2007-03-16 2010-07-01 コニカミノルタエムジー株式会社 コア／シェル型半導体ナノ粒子の製造方法とそれを用いて製造された半導体ナノ粒子集合体
US8062215B2 (en) * 2007-04-13 2011-11-22 Ethicon Endo-Surgery, Inc. Fluorescent nanoparticle scope
JP2010535938A (ja) * 2007-07-24 2010-11-25 ノースウェスタン ユニバーシティ 被覆されたコロイド物質
DE602007011060D1 (de) * 2007-08-13 2011-01-20 Procter & Gamble Internat Operations Sa Sprühtrocknungsverfahren zur Herstellung farbstoffhaltiger Teilchen
US7939560B2 (en) * 2007-09-22 2011-05-10 Boise State University Fluorescent particles comprising nanoscale ZnO layer and exhibiting cell-specific toxicity
KR100954612B1 (ko) * 2007-12-14 2010-04-26 한국화학연구원 양자점을 이용한 약물전달체
KR101487022B1 (ko) * 2008-07-22 2015-01-29 엘지전자 주식회사 압축기
GB0818864D0 (en) * 2008-10-15 2008-11-19 Dow Corning Fabric and fibre conditioning additives
WO2010055529A2 (en) * 2008-11-14 2010-05-20 Indian Association For The Cultivation Of Science Nontoxic, water-soluble and functionalized transition metal ion doped semiconductor nanocrystals and a process for the preparation thereof
CN101531827B (zh) * 2009-04-16 2013-01-09 西安工程大学 活性橙/ZnO核壳结构纳米复合材料及制备方法
US11291974B2 (en) 2009-06-01 2022-04-05 Waters Technologies Corporation Hybrid inorganic/organic materials having novel surface modification; process for the preparation of inorganic/organic hybrid materials; and use of said particles for chromatographic separations
WO2012018596A2 (en) 2010-07-26 2012-02-09 Waters Technologies Corporation Superficially porous materials comprising a substantially nonporous hybrid core having narrow particle size distribution; process for the preparation thereof; and use thereof for chromatographic separations
US11439977B2 (en) 2009-06-01 2022-09-13 Waters Technologies Corporation Hybrid material for chromatographic separations comprising a superficially porous core and a surrounding material
CN101580710B (zh) * 2009-06-22 2012-12-05 暨南大学 一种荧光纳米复合粒子及其制备方法和应用
WO2011025602A1 (en) * 2009-07-20 2011-03-03 The Board Of Regents Of The University Of Texas System Combinational multidomain mesoporous chips and a method for fractionation, stabilization, and storage of biomolecules
US20110046240A1 (en) * 2009-08-24 2011-02-24 Keizer Timothy S Calcium-based carrier particles
US20110046239A1 (en) * 2009-08-24 2011-02-24 Keiser Bruce A Calcium based carrier particles
US20110046241A1 (en) * 2009-08-24 2011-02-24 Keizer Timothy S Calcium based carrier particles
US20110046238A1 (en) * 2009-08-24 2011-02-24 Keiser Bruce A Calcium based carrier particles
US9149544B2 (en) * 2009-11-06 2015-10-06 The Penn State Research Foundation Bioconjugation of calcium phosphosilicate nanoparticles for selective targeting of cells in vivo
US20120329790A1 (en) * 2009-11-23 2012-12-27 University Of Medicine And Dentistry Of New Jersey Dentinal Drug Delivery Composition
US20130135610A1 (en) * 2009-12-15 2013-05-30 Waters Technologies Corporation Device and methods for performing size exclusion chromatography
JPWO2011077838A1 (ja) * 2009-12-25 2013-05-02 コニカミノルタエムジー株式会社 蛍光物質内包シリカナノ粒子及び生体物質標識剤
WO2011081874A1 (en) * 2009-12-29 2011-07-07 W. R. Grace & Co.-Conn. Composite inorganic particles and methods of making and using the same
US8871310B2 (en) * 2010-02-23 2014-10-28 Snu R&Db Foundation Surface-modified tantalum oxide nanoparticles, preparation method thereof, and contrast medium for X-ray computed tomography and highly dielectric thin film using same
US20130108552A1 (en) * 2010-03-01 2013-05-02 University Of Florida Research Foundation Inc. Near-ir indocyanine green doped multimodal silica nanoparticles and methods for making the same
CN102883800B (zh) * 2010-03-08 2016-03-02 巴斯夫欧洲公司 生产纳米颗粒悬浮液的方法
US8518288B2 (en) 2010-07-27 2013-08-27 Toyota Motor Engineering & Manufacturing North America, Inc. Synthesis of nanocomposite thermoelectric material
KR20130100290A (ko) 2010-08-30 2013-09-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 협착성 병변을 위한 전단 제어 방출 및 혈전 용해 치료법
US20120208026A1 (en) * 2011-02-10 2012-08-16 Xerox Corporation Silica-Coated Magnetic Nanoparticles and Process for Making Same
US20140248322A1 (en) * 2011-04-04 2014-09-04 Robert L. Karlinsey Dental compositions containing silica microbeads
US20140154296A1 (en) * 2011-04-04 2014-06-05 Robert L. Karlinsey Dental compositions containing silica microbeads
US9724277B2 (en) * 2011-04-04 2017-08-08 Robert L. Karlinsey Microbeads for dental use
WO2014014970A1 (en) * 2012-07-18 2014-01-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method of preparing silica-coated nanodiamonds
KR101334145B1 (ko) * 2013-01-08 2013-11-28 주식회사 케이엠티알 슈퍼 옥사이드 생성 조성물의 제조방법 및 이 방법에 의해 제조된 슈퍼 옥사이드 생성 조성물
CN103616421B (zh) * 2013-11-28 2015-08-19 信阳师范学院 一种基于铜@碳球核壳材料的罗丹明b电化学传感器及其制备方法与应用
CN108299644A (zh) 2013-12-09 2018-07-20 3M创新有限公司 可固化倍半硅氧烷聚合物、组合物、制品和方法
US10775304B2 (en) * 2014-05-23 2020-09-15 UNIVERSITé LAVAL Fluorescent nanosensors and uses thereof
US10370564B2 (en) 2014-06-20 2019-08-06 3M Innovative Properties Company Adhesive compositions comprising a silsesquioxane polymer crosslinker, articles and methods
US10392538B2 (en) 2014-06-20 2019-08-27 3M Innovative Properties Company Adhesive compositions comprising a silsesquioxane polymer crosslinker, articles and methods
CN104138757B (zh) * 2014-07-25 2016-03-02 浙江师范大学 一种二氧化钛/金核壳结构复合纳米颗粒及其制备方法
US9957358B2 (en) 2014-09-22 2018-05-01 3M Innovative Properties Company Curable polymers comprising silsesquioxane polymer core silsesquioxane polymer outer layer, and reactive groups
US9957416B2 (en) 2014-09-22 2018-05-01 3M Innovative Properties Company Curable end-capped silsesquioxane polymer comprising reactive groups
CN104897889B (zh) * 2015-05-28 2017-03-01 山东省医学科学院基础医学研究所 荧光SiO2胶体试剂的制备方法及使用荧光SiO2胶体试剂的试纸
HU231076B1 (hu) * 2015-07-31 2020-06-29 Szegedi Tudományegyetem Hatóanyagoknak a központi idegrendszerben történő szabályozott leadására alkalmas nanokompozit, eljárás annak előállítására és alkalmazása
WO2017155848A1 (en) 2016-03-06 2017-09-14 Waters Technologies Corporation Porous materials with controlled porosity; process for the preparation thereof; and use thereof for chromatographic separations
CN108883317A (zh) * 2016-04-18 2018-11-23 麦迪那股份公司 包含2h和18o同位素贫化水的化妆品组合物
JP6967256B2 (ja) * 2016-08-31 2021-11-17 国立大学法人 名古屋工業大学 ナノシリカ中空粒子の製造方法
WO2018049172A1 (en) 2016-09-08 2018-03-15 The Penn State Research Foundation Handheld device and multimodal contrast agent for early detection of human disease
KR20210057116A (ko) * 2018-09-13 2021-05-20 더 리젠츠 오브 더 유니버시티 오브 미시간 치료, 영상화 및 치료진단 적용을 위한 소형의 고도로 균일한 나노약물 조성물
CN110669141A (zh) * 2019-09-29 2020-01-10 杭州联科生物技术股份有限公司 一种别藻蓝蛋白(APC)与Annexin V蛋白偶联方法
KR102304582B1 (ko) * 2020-01-30 2021-09-24 창원대학교 산학협력단 우수한 분산성 및 균일한 입도를 가지는 나노분말의 제조방법
CN111504855A (zh) * 2020-04-14 2020-08-07 王阳 一种制备多功能多位点示踪纳米颗粒的方法
CN113636902A (zh) * 2020-04-27 2021-11-12 南京理工大学 一种氟基铝热剂及其制备方法
WO2021231771A2 (en) 2020-05-14 2021-11-18 Ariz Precision Medicine CANCER TREATMENT USING siRNA TO MODULATE EXPRESSION OF PRDM2/RIZ PROTEIN
CA3194232A1 (en) 2020-09-29 2022-04-07 Daniel Beard Stroke treatment
CN112858252B (zh) * 2021-01-05 2022-04-15 中山大学 Ti3C2Tx复合材料在检测呋喃妥因和氧氟沙星中的应用和检测方法
CN113199034B (zh) * 2021-03-05 2022-11-01 北京服装学院 一种Ag-SiO2复合微球及其制备方法和应用
CN113264765B (zh) * 2021-06-25 2022-07-12 中国航发北京航空材料研究院 一种HfO2-Si喷涂材料及其制备方法
CN114437711B (zh) * 2022-01-07 2023-09-29 南京航空航天大学 一种用于交通设施行车安全提示的长辉光粉微壳材料及其制备方法
CN114292593B (zh) * 2022-01-17 2022-08-26 山东中凯华瑞工程材料有限公司 一种纳米微米和亚微米微米间隔结构仿生全疏材料及其制备方法
CN114654829B (zh) * 2022-04-09 2023-11-17 江西鑫远基电子科技有限公司 一种高击穿电压的铝基覆铜板及其生产工艺
CN115011056B (zh) * 2022-07-01 2023-09-15 东北林业大学 一种核壳乳胶粒包覆无机纳米颗粒的复合乳液及其组装方法
CN114984875A (zh) * 2022-07-13 2022-09-02 西安交通大学 一种金属-酰肼配位自组装纳米球及其制备方法与应用
CN116492977B (zh) * 2023-03-15 2025-01-28 中国农业大学 铁氢氧化物包裹的dna磷示踪剂及其制备方法与应用
CN116920750A (zh) * 2023-08-10 2023-10-24 南京宇源新能碳中和科技有限公司 一种利用水凝胶颗粒模板制备的多孔微通道反应器及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0611394B2 (ja) 1990-09-03 1994-02-16 工業技術院長 安定化エマルションの製造方法
US6258351B1 (en) * 1996-11-06 2001-07-10 Shearwater Corporation Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
US6413489B1 (en) * 1997-04-15 2002-07-02 Massachusetts Institute Of Technology Synthesis of nanometer-sized particles by reverse micelle mediated techniques
US6578264B1 (en) * 1999-06-04 2003-06-17 Cascade Microtech, Inc. Method for constructing a membrane probe using a depression
AUPQ573300A0 (en) 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
GB0009773D0 (en) * 2000-04-19 2000-06-07 Univ Cardiff Particulate composition
US6548264B1 (en) 2000-05-17 2003-04-15 University Of Florida Coated nanoparticles
WO2002028912A2 (en) * 2000-10-06 2002-04-11 Carnegie Mellon University Preparation of nanocomposite structures by controlled polymerization
DE10164768A1 (de) 2001-06-29 2003-10-02 Itn Nanovation Gmbh Nanoskalige Kern-Hülle-Teilchen
IN192520B (enExample) * 2001-08-01 2004-04-24 Univ Delhi
US7524630B2 (en) * 2002-04-22 2009-04-28 University Of Florida Research Foundation, Inc. Functionalized nanoparticles and methods of use
US7189417B2 (en) * 2002-05-01 2007-03-13 The Trustees Of The University Of Pennsylvania Nanometer-sized carrier medium
GB0220383D0 (en) * 2002-08-31 2002-10-09 Holset Engineering Co Mehod of reducing high cycle fatigue of turbochargers
US20040115239A1 (en) 2002-09-20 2004-06-17 Shastri Venkatram P. Engineering of material surfaces
US9028863B2 (en) * 2003-04-25 2015-05-12 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
KR20070028478A (ko) 2004-06-01 2007-03-12 더 펜 스테이트 리서치 파운데이션 비응집성 코어/쉘 나노복합 입자

Also Published As

Publication number Publication date
WO2005118702A2 (en) 2005-12-15
WO2005118702A3 (en) 2007-11-15
EP1773936A2 (en) 2007-04-18
JP2008501509A (ja) 2008-01-24
CA2569067A1 (en) 2005-12-15
AU2005250464A1 (en) 2005-12-15
CA2569067C (en) 2013-04-02
EP1773936A4 (en) 2008-10-08
US20050281884A1 (en) 2005-12-22
EP1773936B1 (en) 2015-09-02
KR20070028478A (ko) 2007-03-12
US8071132B2 (en) 2011-12-06

Similar Documents

Publication Publication Date Title
AU2005250464B2 (en) Unagglomerated core/shell nanocomposite particles
Louis et al. Nanosized hybrid particles with double luminescence for biological labeling
Fery-Forgues Fluorescent organic nanocrystals and non-doped nanoparticles for biological applications
Kim et al. Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer‐targeted imaging and magnetically guided drug delivery
Pal et al. Nanoparticle: An overview of preparation and characterization
US9550160B2 (en) Methods for producing nanoparticles and using same
Maldiney et al. Mesoporous persistent nanophosphors for in vivo optical bioimaging and drug-delivery
Kim et al. In vivo NIR imaging with CdTe/CdSe quantum dots entrapped in PLGA nanospheres
Roy et al. Ormosil nanoparticles as a sustained-release drug delivery vehicle
Sha et al. Manganese-doped gold core mesoporous silica particles as a nanoplatform for dual-modality imaging and chemo-chemodynamic combination osteosarcoma therapy
Hemmer et al. In vitro and in vivo investigations of upconversion and NIR emitting Gd2O3: Er3+, Yb3+ nanostructures for biomedical applications
Wang et al. Lipid coated upconverting nanoparticles as NIR remote controlled transducer for simultaneous photodynamic therapy and cell imaging
Voliani Gold nanoparticles: an introduction to synthesis, properties and applications
Fu et al. A versatile upconversion surface evaluation platform for bio–nano surface selection for the nervous system
Bando et al. Electric charge dependence of controlled dye-release behavior in glass ionomer cement containing nano-porous silica particles
KR101973846B1 (ko) 고분자-산화철 복합 나노구조체, 이의 이용방법, 및 이의 제조방법
Chang et al. Controlled growth of fluorescent silica nanoparticles using two-phase orthogonal solvents for bioimaging
Rouse Synthesis and properties of unagglomerated nanocomposite particles for nanomedical applications
Feng Biodegradable Nanoassemblies for Biomedical Applications
Xu et al. Hydrophobic Modification of Copper Nanospheres for Incorporation into Poloxamer Micelles, Aggregated Micellar Nanocages and Supramolecular Assemblies
Silbaugh Fluorescent silicon nanocrystals for bioimaging
Liu Microcapsule-Mediated Delivery Platform for Independent Investigations of Intracellular Nanodrugs Diffusion Kinetics and Nanoplastic Biodegradation
Lee Synthesis of Polymer Nanocomposites via Electrohydrodynamic (EHD)-mediated Mixing and Emulsification
Suri et al. CHAPTER I. 2.19 MICROPARTICLES AND NANOPARTICLES
Chang Luminescent silicon quantum dots as a base for multimodal nanoplatforms

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired